Neuroone Medical Technologies Corp (NMTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has a cash flow conversion efficiency ratio of -0.247x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.33 Million) by net assets ($5.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Neuroone Medical Technologies Corp to measure how much of total assets are equity-financed.
Neuroone Medical Technologies Corp - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Neuroone Medical Technologies Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Neuroone Medical Technologies Corp to evaluate the quality of earnings relative to operating cash generation.
Neuroone Medical Technologies Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuroone Medical Technologies Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sahathai Terminal Public Company Limited
BK:PORT
|
0.050x |
|
Eagle Plains Resources Ltd.
V:EPL
|
-0.112x |
|
Orege Société Anonyme
PA:OREGE
|
0.034x |
|
TPC Co. Ltd
KQ:130740
|
0.007x |
|
Acrinova AB
ST:ACRI-A
|
0.092x |
|
Denali Capital Acquisition Corp. Class A Ordinary Shares
NASDAQ:DECA
|
0.008x |
|
RENALYTIX PLC LS-0025
F:2O9
|
N/A |
|
Magnum Ventures Limited
NSE:MAGNUM
|
0.008x |
Annual Cash Flow Conversion Efficiency for Neuroone Medical Technologies Corp (2010–2025)
The table below shows the annual cash flow conversion efficiency of Neuroone Medical Technologies Corp from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Neuroone Medical Technologies Corp.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $7.07 Million | $-2.84 Million | -0.401x | +97.01% |
| 2024-09-30 | $822.01K | $-11.01 Million | -13.396x | -549.64% |
| 2023-09-30 | $6.25 Million | $-12.89 Million | -2.062x | -163.38% |
| 2022-09-30 | $9.60 Million | $-7.52 Million | -0.783x | +40.35% |
| 2021-09-30 | $6.55 Million | $-8.60 Million | -1.313x | +20.82% |
| 2020-09-30 | $2.07 Million | $-3.43 Million | -1.658x | -138.02% |
| 2019-09-30 | $-1.24 Million | $-5.40 Million | 4.360x | +577.83% |
| 2018-09-30 | $-4.40 Million | $-2.83 Million | 0.643x | +711.35% |
| 2017-09-30 | $-266.22K | $-21.11K | 0.079x | -78.63% |
| 2016-09-30 | $-81.49K | $-30.23K | 0.371x | -49.84% |
| 2015-09-30 | $-35.39K | $-26.17K | 0.740x | -16.60% |
| 2014-09-30 | $-28.30K | $-25.09K | 0.887x | +11.30% |
| 2013-09-30 | $-17.24K | $-13.73K | 0.797x | 0.00% |
| 2012-09-30 | $-17.24K | $-13.73K | 0.797x | -90.48% |
| 2011-09-30 | $-3.28K | $-27.43K | 8.370x | +610.58% |
| 2010-09-30 | $-4.32K | $-5.09K | 1.178x | -- |
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more